1.
Dev Biol Stand
; 39: 129-34, 1977.
Article
in English
| MEDLINE
| ID: mdl-604095
ABSTRACT
Measurements of peak flow, vital capacity, FEV1 and flow volume studies were performed in healthy volunteers for 20 weeks following intranasal vaccination with live-attenuated A/Victoria/3/75 recombinants or placebo. Despite differing attenuation of the two candidate strains, no effect on pulmonary function was detected.